Eyenovia Shares Are Trading Higher After the Company Announced the Launch of a New FDA-Approved Ophthalmic Drug Along With Formosa Pharma.
Eyenovia Shares Are Trading Higher After the Company Announced the Launch of a New FDA-Approved Ophthalmic Drug Along With Formosa Pharma.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.